RECURSION PHARMACEUTICALS, INC. Other Current Assets
RECURSION PHARMACEUTICALS, INC. (RXRX) had Other Current Assets of $29.32 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Current $29.32M.
- 2026-03-31: Other Assets, Current $24.25M.
- 2025-12-31: Other Assets, Current $28.57M.
- 2025-09-30: Other Assets, Current $29.22M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $29.32M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $24.25M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $28.57M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $29.22M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $37.34M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $32.02M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $38.11M 10-K · filed 2026-02-25 | $67.71M 10-K · filed 2025-02-28 |
| 2024-09-30 | $42.72M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $43.73M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $41.49M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $40.25M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $17.78M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $18.77M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $15.61M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $15.87M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $13.25M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $16.98M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $15.43M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $7.51M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $9.45M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $4.62M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $2.62M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $2.15M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |